BCR and chronic myelogenous leukemia, BCR-ABL1 positive: However, imatinib did not stimulate the nuclear import of the Y253E mutant (Figure 5B), which is consistent with the fact that BCR-ABLY253H was an imatinib-resistant mutant isolated from drug-resistant CML cells [35].